HOME >> MEDICINE >> NEWS
7th Annual AIDS Science Day at Yale April 22

The Center for Interdisciplinary Research on AIDS (CIRA) will host the 7th Annual AIDS Science Day on Friday, April 22 at the Omni New Haven Hotel at Yale, 155 Temple St.

CIRAaffiliated scientists from Yale, the Hispanic Health Council and The Institute for Community Research, will present their findings to scientific and community members. The event is free and open to the public, but registration is required for lunch. Attendees will have the opportunity to learn about the latest research in HIV/AIDS prevention, treatment and care. It will also offer an opportunity to improve existing HIV/AIDS programs and to build coalitions to support improved services. Another goal is to increase collaboration between the community and the university. The event is sponsored by CIRA.

Events include panel presentations, a poster session, 18 community booths and a keynote address by George Ayala, director of the Institute for Gay Men's Health. Ayala's talk is titled "Holding Open Space: Retooling and ReImagining HIV Prevention Research for Gay and Bisexual Men."

Also on display throughout the conference will be a traveling photo exhibit titled "Giving Women Power Over AIDS," sponsored by the Global Campaign for Microbicides. The exhibit will travel to Philadelphia, Seattle, Sacramento, San Francisco, Los Angles, Atlanta, Washington, D.C., Baltimore, Chicago, Hartford, New York City and Boston.

The day's agenda includes:

8:15 to 9 a.m.: Poster Set Up and Registration

9 a.m. to 12 noon: Welcoming Remarks & Start of Program

  • "Where the Boys Are: HIV Risk and Men's Health"
  • "Trainspotting: Implications of Drug Use Preparation and Treatment for HIV Risk and Prevention"
  • "The Color Purple: HIV Risk and Prevention Among Women and Children"

12 noon to 1:30 p.m.:

  • Lunch (PreRegistrants Only)
  • Community Booths and Poster Sessions
<
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
12-Apr-2005


Page: 1 2

Related medicine news :

1. AIUM hosts Third Annual Ultrasound Practice Forum
2. Pfizer Onocology press briefing scheduled during ASCO 2007 Annual Meeting
3. News from American Psychiatric Association 2007 Annual Meeting
4. Interventional cardiologists assemble in Orlando, Fla., for SCAI Annual Scientific Sessions
5. SNMs 54th Annual Meeting speakers address state of molecular imaging/nuclear medicine technologies
6. Annual meeting of the National Academy of Sciences
7. Nancy Brinker and Lance Armstrong honored with Centennial Medals at the AACR 2007 Annual Meeting
8. 2007 ARVO Annual Meeting draws spotlight on aging eye
9. Annual study finds top hospitals have 28 percent lower mortality rate
10. AIUM to host Annual Convention
11. American Society of Biomechanics Annual Meeting Sept. 6-9

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Annual AIDS Science Day Yale April

(Date:10/22/2014)... (PRWEB) October 22, 2014 Shriners Hospitals ... that will change the current location of Shriners Hospitals ... South Limestone across from the University of Kentucky Albert ... state-of-the-art ambulatory care center, owned and operated by Shriners ... orthopaedic needs of children and their families well into ...
(Date:10/22/2014)... October 22, 2014 During the Western ... water supply runs dangerously low, Southern Oregon’s water is ... rivers, despite the lowest mountain snow pack on record ... summer and early autumn.* That was the observation of ... new book “Hiking Southern Oregon,” during an interview with ...
(Date:10/22/2014)... Although there are only 24 hours in a ... who have trouble finding time within their busy schedules for exercise ... periods of time to get in shape. Here are five ways ... go. , Change Up Your Commute , Consider riding a ... some exercise into your daily routine. If you must use your ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... be showing a genetic propensity for obesity as toddlers, a ... linked to increased body fat, but the same genes in ... researchers said. At 1 year, kids with these genes ... however, these genes were linked to excessive weight gain, the ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... A crucial part of conventional in vitro fertilization (IVF) -- ... instead take place in a device inside the vagina, new ... contend that the device, called an INVOcell, might sharply cut ... also make the technology more accessible to those who don,t ...
Breaking Medicine News(10 mins):Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
(Date:10/22/2014)... Calif. , Oct. 22, 2014 WHEN: ... EDTLOCATION: Online, complimentary registration available at: ... Leader Archana Vidyasekar and Visionary Innovation Research ... WiFi-like wireless electricity, self-assembling materials, nanobots and ... technologies which will transform our lives in ...
(Date:10/22/2014)... Oct. 22, 2014  Regulus Therapeutics Inc. ... company leading the discovery and development of ... it has demonstrated human proof-of-concept with a ... evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting ... C virus infection ("HCV").  Interim results from ...
(Date:10/20/2014)... Oct. 20, 2014  Luoxis Diagnostics, Inc., a ... today announced that its academic collaborators will present ... potential for its novel RedoxSYS Diagnostic System, a ... the body in response to injury or illness.  ... as a clinical marker will be presented by ...
Breaking Medicine Technology:Futuristic Technologies That Will Transform Our World Beyond 2030 2Futuristic Technologies That Will Transform Our World Beyond 2030 3Futuristic Technologies That Will Transform Our World Beyond 2030 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
Cached News: